OncoTarget

Herausgeber

Impact Journals Llc

Electronic International Standard Serial Number ( EISSN )

1949-2553

ISSN gedruckt

1949-2553

WoS ID

URL

http://www.bibliothek.uni-regensburg.de/ezeit/?2560162

Weitere Details

2019

The interplay of CDK4 and CDK6 in melanoma.

2018

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma.

2018

Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.

2018

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma.

2017

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.

2017

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model

2017

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials.

2017

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

2017

Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474.

2017

Nutrient deprivation in neuroblastoma cells alters 4-hydroxynonenal-induced stress response.

2017

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses

2017

Opioids: Modulators of angiogenesis in wound healing and cancer

2017

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib.

2017

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.

2017

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer"s syndrome.

2016

An oncogenic role for sphingosine kinase 2.

2016

Characterization of the novel indolylmaleimides" PDA-66 and PDA-377 effect on canine lymphoma cells.

2016

Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.

2016

DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.

2016

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

2016

Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer.

2016

The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth

2016

The second European interdisciplinary Ewing sarcoma research summit - A joint effort to deconstructing the multiple layers of a complex disease

2015

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.

2015

Effects of RAL signal transduction in KRAS- and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer.

2015

Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.

2015

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model

2014

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia.

2014

Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia.

2014

SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.

2013

CDK6 and p16INK4A in lymphoid malignancies.

2013

Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.

2012

STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia.

2011

Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias.

2011

Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".

2011

c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format

2019

The interplay of CDK4 and CDK6 in melanoma.

2018

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma.

2018

Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.

2018

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma.

2017

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.

2017

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model

2017

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials.

2017

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

2017

Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474.

2017

Nutrient deprivation in neuroblastoma cells alters 4-hydroxynonenal-induced stress response.

2017

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses

2017

Opioids: Modulators of angiogenesis in wound healing and cancer

2017

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib.

2017

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.

2017

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer"s syndrome.

2016

An oncogenic role for sphingosine kinase 2.

2016

Characterization of the novel indolylmaleimides" PDA-66 and PDA-377 effect on canine lymphoma cells.

2016

Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.

2016

DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.

2016

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

2016

Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer.

2016

The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth

2016

The second European interdisciplinary Ewing sarcoma research summit - A joint effort to deconstructing the multiple layers of a complex disease

2015

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.

2015

Effects of RAL signal transduction in KRAS- and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer.

2015

Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.

2015

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model

2014

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia.

2014

Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia.

2014

SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.

2013

CDK6 and p16INK4A in lymphoid malignancies.

2013

Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.

2012

STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia.

2011

Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias.

2011

Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".

2011

c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format